- Posted July 25, 2013 by Doron Schneider, MD, FACP
- Posted July 24, 2013 by John L. Leahy, MD
- Posted June 12, 2013 by John L. Leahy, MD
Doron Schneider, MD and Jack Leahy, MD discuss the importance of patient BMI and other risk factors for coronary artery disease when weighing treatment options.
- Posted May 29, 2013 by John L. Leahy, MD
Dr. Jack Leahy, endocrinologist and general internist, Dr. Doron Schneider, weigh different initial treatment options presented by leading endocrinologists Silvio Inzucchi, MD, Alan J. Garber, MD and Laurence Kennedy, MD
- Posted March 18, 2013 by Jay Shubrook, DO, FACOFP, FAAFP
There is almost no other disease as pervasive as type 2 diabetes, a disease that has touched almost every family in America. Although there was a time when we had limited management tools, we now have ten classes of medications plus many kinds of insulin available as options. The result is a choice of many treatment combinations, which, however welcome, can also be overwhelming for the practicing physician. With so many choices it becomes very hard to decide what comes after metformin.
The Good, The Bad, and the Ugly Part II: Why I’m not a Fan of the ADA/EASD’s 2012 Position StatementPosted June 6, 2012 by John L. Leahy, MD
- Posted May 30, 2012 by John L. Leahy, MDThe highly awaited ADA/EASD statement on management of type 2 diabetes was published online April 19th, 2012.1 I feel like a curmudgeon,but as a general statement, I’m not a fan. In fact, I’m worried that at best it will have little impact, and at worst could be harmful.
- Posted April 26, 2012 by Kevin A. Peterson, MD, MPH
The patient centered medical home (PCMH) model has been considered a hallmark for high quality health care. Although the concept of coordinated care is fundamental to the principle of the PCMH, and although primary care teams are increasingly integrating patient- and family-centered approaches into their practice workflow for diabetes support,1 primary care physicians still need to develop a better understanding of how to coordinate population-based management of diabetes while maintaining a patient–centered approa
- Page 1 of 2